
Trulieve Named to TIME's America's Best Companies 2026 List
PRNewsWire
Published: Jul 10, 2026, 11:45 AM
Sentiment Analysis
Trulieve Cannabis Corp. (NYSE: TRLV ) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that it has been named to TIME's list of America's Best Companies 2026 . Compiled by TIME and Statista, the annual list recognizes the top 1,000 companies in the United States based on employee satisfaction, financial strength, and sustainability transparency.
"Being named to TIME's list of America's Best Companies is a tremendous honor and a direct reflection of the durability of our business," said Trulieve's Chief Executive Officer Kim Rivers. "To be one of only two cannabis companies recognized speaks to the passion and dedication of our team as we continue our mission to expand access to cannabis."
More than 7,200 companies met the eligibility criteria for consideration, and Trulieve is one of only two cannabis companies to earn a place on the list. The TIME America's Best Companies 2026 ranking identifies top-performing U.S. companies through a data-driven evaluation across three dimensions: Employee Satisfaction — based on approximately 217,000 employee surveys assessing workplace culture, pay, working conditions, and employer reputation; Financial Performance — an analysis of revenue growth, profitability, and asset performance using multi-year financial data, limited to companies with a minimum of $100 million in revenue; and Sustainability Transparency — an evaluation of environmental impact, social responsibility, and governance practices using Statista's database and additional research. The full list is available at TIME.com .
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established medical marijuana operations in Florida, Georgia, Pennsylvania, and West Virginia. Driven by a core mission to expand access to cannabis, Trulieve serves customers with i...
Source: PRNewsWire
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.